TP53 and neoplasm: Similarly, targeting myeloid-derived suppressor cells (MDSCs) for ferroptosis, by inhibiting ASAH2-mediated suppression of the p53–haeme oxygenase 1 (HMOX1) axis, activates tumor-infiltrating cytotoxic CD8+ T cells and suppresses tumors (114, 115).